Awesome FinTech
Get access
feedback
FOXO Technologies commercializes epigenetic testing services and technology to support scientific discoveries and disruptive business initiatives for the research community and longevity industry. It adds value to the longevity insurance industry with a tech-based underwriting protocol and consumer engagement platform based on epigenetics.
Total funding
~$10M
HQ 🇺🇸
Minneapolis, United States
Year founded
2016
Status
Alive
People
Jon Sabes
Chief Executive Officer
James W Jacobson
President, Executive Vice President
Robby Potashnick
Chief Financial Officer
Steve Sabes
Chief Operating Officer
Tyler Danielson
Chief Technology Officer
C. Jennifer Hubbell
Senior Vice President
Investors
Bespoke Capital Partners
Categories
Share
Get access to exclusive data about FOXO Technologies
Access FOXO Technologies now
Categories